Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 6.85
3.63 %
$ 16.4 M
Market Cap
-0.63
P/E
CASH FLOW STATEMENT
-5.77 M
OPERATING CASH FLOW
-199 K
INVESTING CASH FLOW
6.66 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Innovative Eyewear, Inc.
| Net Income | -6.66 M |
| Depreciation & Amortization | 85.3 K |
| Capital Expenditures | -251 K |
| Stock-Based Compensation | 937 K |
| Change in Working Capital | -364 K |
| Others | -125 K |
| Free Cash Flow | -6.02 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (6.7) | (5.7) | (3.2) | (0.8) | (0.1) |
| Depreciation & Amortization | 85.3 K | 32.6 K | 7.68 K | 994 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0.1 | 0 |
| Stock Based Compensation | 0.9 | 1.5 | 1.3 | 81.6 K | 0 |
| Other Operating Activities | 0.2 | 1.2 | 0.9 | 0.5 | 0.1 |
| Change in Working Capital | (0.4) | (0.2) | (0.2) | 8.22 K | 0 |
| Cash From Operations | (5.8) | (3.2) | (1.2) | 40.3 K | 0 |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.3) | (0.2) | (0.1) | 59 K | 0 |
| Other Items | 52.7 K | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (0.2) | (0.2) | (0.1) | 59 K | 0 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (0.1) | 0.8 | 1.0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.7 | 6.68 K | (0.1) | 0 | 0 |
| Cash From Financing Activities | 6.7 | 7.0 | 1.4 | 0.1 | 0 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 0.7 | 3.5 | 52.7 K | 27 K | 0 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (6.0) | (3.4) | (1.3) | 99.3 K | 0 |